Author:
Chauhan Anahita R.,Nandanwar Yogeshwar S.,Ramaiah Aruna,Yelikar Kanan A.,Rashmi M. D.,Sachan Rekha,Mayekar Rahul V.,Trivedi Yamini N.,Paradkar Gopalkrishna V.,Patole Kiran P.
Funder
Bharat Serums and Vaccines Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference16 articles.
1. Kent J, Farrell AM, Soothill P. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. BMC Pregnancy Childbirth. 2014;14(1):87.
2. Bolton-Maggs PH, Davies T, Poles D, et al. Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG Int J Obstet Gynaecol. 2013;120(7):873–8.
3. Olovnikova N. Anti-RhD-mediated immunosuppression: can monoclonal antibodies imitate the action of polyclonal antibodies?. In: Immunosuppression-role in health and diseases 2012. InTech.
4. McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2015;9(2):CD000020.
5. Dajak S, Roje D, Hašpl ŽH, et al. The importance of antenatal prevention of RhD immunisation in the first pregnancy. Blood Transfus. 2014;12(3):410.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献